concept

RESVERATROL

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about RESVERATROL: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

341Connections

1Hypotheses

2Analyses

50Outgoing

50Incoming

0Experiments

3Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	RESVERATROL
Key Genes/Proteins	AKT, AMPK, AMYLOID, aplp1, APOE
Related Diseases	ACETYLCHOLINE, aging, ALZHEIMER, Alzheimer'S Disease, ALZHEIMER'S DISEASE
Related Pathways	AMPK PATHWAY

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Resveratrol and Sirtuin Activation for Neurodegeneration

therapeutic · 1841 words

→

Pathway Diagram

graph TD
    RESVERATROL["RESVERATROL"]
    RESVERATROL -.protects against.-> UVA_Induced_Photoaging["UVA-Induced Photoaging"]
    RESVERATROL -->|"activates"| SIRT1["SIRT1"]
    RESVERATROL -->|"reduces_phosphorylation_of"| IRS1["IRS1"]
    RESVERATROL -->|"mediates"| AMPK_Phosphorylation["AMPK Phosphorylation"]
    RESVERATROL -->|"activates"| insulin_signaling["insulin signaling"]
    RESVERATROL -->|"inhibits"| Apoptosis["Apoptosis"]
    RESVERATROL -->|"inhibits"| Collagen_Fiber_Degradation["Collagen Fiber Degradation"]
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -.biomarker for.-> RESVERATROL
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"target for"| RESVERATROL
    FOXO1["FOXO1"] -->|"activates"| RESVERATROL
    FIBROBLASTS["FIBROBLASTS"] -->|"activates"| RESVERATROL
    AUTOPHAGY["AUTOPHAGY"] -->|"activates"| RESVERATROL
    CELL_CYCLE["CELL CYCLE"] -->|"activates"| RESVERATROL
    APOPTOSIS["APOPTOSIS"] -->|"activates"| RESVERATROL

Outgoing (200)

Target	Relation	Type	Str
UVA-Induced Photoaging	protects_against	disease	0.95
AMPK Phosphorylation	mediates	process	0.90
SIRT1	activates	protein	0.90
IRS1	reduces_phosphorylation_of	protein	0.90
Axonal Degeneration	protects_against	process	0.90
SIRT1-DBC1 Complex	modulates	mechanism	0.85
Collagen Fiber Degradation	inhibits	process	0.85
SIRT1	activates	protein	0.85
Apoptosis	inhibits	process	0.85
insulin signaling	activates	pathway	0.85
mitochondrial biogenesis	promotes	process	0.80
AMPK	activates	protein	0.80
autophagy	modulates	process	0.80
Inflammatory Response	inhibits	process	0.80
insulin resistance	protects_against	disease	0.80
mitochondrial function	associated_with	phenotype	0.80
diet-induced obesity	protects_against	disease	0.80
SIRT1	modulates	gene	0.80
TAU	associated_with	protein	0.80
AMPK	activates	protein	0.80
gut microbiota dysbiosis	prevents	phenotype	0.75
NAD+ metabolism	modulates	pathway	0.75
AGING	modulates	process	0.75
Skin Fibroblasts	expressed_in	cell_type	0.75
ALZHEIMER'S DISEASE	treats	disease	0.75
CDK5	modulates	gene	0.75
DNA	targets	gene	0.70
AD	targets	disease	0.70
Alzheimer's disease	treats	disease	0.70
Cognitive Dysfunction	associated_with	phenotype	0.70
Cgas-Sting Pathway	inhibits	pathway	0.70
inflammation	regulates	process	0.70
miRNA	regulates	process	0.70
alcohol-induced neurodegeneration	protects_against	disease	0.70
AMPK	targets	gene	0.70
oxidative stress	regulates	process	0.70
Alzheimer's disease	protects_against	disease	0.70
RELA	treats	gene	0.70
Parkinson's disease	treats	disease	0.70
oxidative stress	protects_against	process	0.70
Oxidative Stress	protects_against	process	0.70
AMPK	regulates	protein	0.70
PROTEIN AGGREGATION	treats	phenotype	0.65
TAU	phosphorylates	gene	0.65
SOD2	regulates	gene	0.65
MAPK	inhibits	gene	0.65
INSULIN SIGNALING	treats	pathway	0.65
ROS	phosphorylates	gene	0.65
NEURODEGENERATION	protects_against	phenotype	0.65
AUTOPHAGY	treats	phenotype	0.65

Incoming (141)

Source	Relation	Type	Str
36237161	has been shown to promote	paper	0.90
36237161	prevents	paper	0.90
36237161	enhances mitochondria biogenesis by acting on	paper	0.90
41892314	suppressed phosphorylation of	paper	0.90
38501412	repairs intestinal barrier by inhibiting	paper	0.90
38501412	improves	paper	0.90
38501412	increases	paper	0.90
38501412	down-regulates	paper	0.90
38501412	repairs	paper	0.90
38501412	inhibits	paper	0.90
38501412	restores	paper	0.90
38501412	protects	paper	0.90
38501412	lowers	paper	0.90
28086917	did not alter	paper	0.90
41892314	inhibits	paper	0.90
26684010	binds directly to	paper	0.90
26684010	binds at the nucleotide pocket of	paper	0.90
26684010	competes with	paper	0.90
41892314	attenuated	paper	0.90
41892314	normalized	paper	0.90
41892314	inhibited translocation of	paper	0.90
41892314	mitigates	paper	0.90
41892314	attenuates	paper	0.90
41892314	normalizes	paper	0.90
41892314	inhibits translocation of STING	paper	0.90
41892314	suppresses	paper	0.90
AMPK	phosphorylates	gene	0.65
NEURON	phosphorylates	cell_type	0.65
AKT	targets	gene	0.65
FERROPTOSIS	treats	phenotype	0.65
ALZHEIMER	treats	disease	0.65
PLP1	interacts_with	gene	0.65
PI3K	targets	gene	0.65
MACROPHAGE	targets	cell_type	0.65
ENDOTHELIAL	targets	cell_type	0.65
RAGE	targets	gene	0.65
PARKIN	expressed_in	gene	0.65
PARKINSON'S DISEASE	treats	disease	0.65
PARKINSON	treats	disease	0.65
PARKIN	treats	gene	0.65
ALZHEIMER'S DISEASE	treats	disease	0.65
28086917	reduces	paper	0.60
28086917	increases	paper	0.60
28086917	decreases	paper	0.60
28086917	does not alter	paper	0.60
28086917	modulates	paper	0.60
28086917	induces	paper	0.60
28086917	attenuates declines in	paper	0.60
PARKINSON	expressed_in	gene	0.50
Alzheimer'S Disease	expressed_in	disease	0.50

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Caloric Restriction Mimetic Combination Therapy (Metformin +	0.640	neurodegeneration	-

Mentioning Analyses (2)

Scientific analyses that reference this entity

Clinical Trial Landscaping for Alzheimer's Disease Therapeutics

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.629

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

neurodegeneration | 2026-04-03 | 43 hypotheses Top: 0.893

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (3)

Multi-agent debates referencing this entity

What is the current clinical trial landscape for AD therapeutics, and which mech

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Is the amyloid concentration in AD clinical trials rational given lecanemab's ap

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

What gene expression changes in the aging mouse brain predict neurodegenerative

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

Related Research

Hypotheses and analyses mentioning RESVERATROL in their description or question text

No additional research found